We are live on ! Find out more
LRND icon

New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF
LRND

3 hedge funds and large institutions have $6.33M invested in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more capital invested

Capital invested by funds: $5.98M → $6.33M (+$349K)

4.26% less ownership

Funds ownership: 91.77% → 87.51% (-4.3%)

25% less funds holding

Funds holding: 4 → 3 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CCP
Clarity Capital Partners
California
+$338K
2
AssetMark Inc
AssetMark Inc
California
+$240

Top Sellers

Rank Fund Capital Flow
1
GS
GTS Securities
Florida
-$597K
2
UBS Group
UBS Group
Switzerland
-$113
3
TRCT
Tower Research Capital (TRC)
New York
-$28

LRND Hedge Fund Activity: Q1 2024 in Review

3 of the 6,961 institutional investors tracked by Wall St. Rank reported a position in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) for Q1 2024, worth a combined $6.33M — up 5.8% from $5.98M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of LRND and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest buyer was Clarity Capital Partners, opening a new position worth an estimated $338K. The largest seller was GTS Securities, exiting entirely with an estimated $597K sold.

  • 3 institutional investors held New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) as of Q1 2024, down from 4 in Q4 2023.
  • Funds reported $6.33M of New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF stock for Q1 2024, up 5.8% quarter-over-quarter.
  • 2 funds opened new New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF positions in Q1 2024 and 3 closed out, a net change of -1 holder.
  • The largest New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF buyer in Q1 2024 was Clarity Capital Partners, an estimated $338K added.
  • The largest New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF seller in Q1 2024 was GTS Securities, an estimated $597K sold.

Based on aggregated 13F filings for Q1 2024.